Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide plus PEG-ELS for bowel preparation before EMR/ESD colonoscopy
ChiCTR2400090039Phase 4Recruiting
- Sponsor
- Beijing Shijitan Hospital
- Start
- Sep 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of linaclotide and polyethylene glycol 3350 + electrolytes in inadequate bowel preparation (IBP) (3 arms), sponsored by Beijing Shijitan Hospital. Primary endpoint: Comfort degree. Started Sep 2024; status: recruiting.
02
Drugs
linaclotidepolyethylene glycol 3350 + electrolytes
03
Conditions
inadequate bowel preparation (IBP)
Beyond the preview
Go deeper on ChiCTR2400090039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090039.